CompletedPhase 3NCT03697109
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome
Studying Adrenal Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Corcept Therapeutics
- Principal Investigator
- Andreas Moraitis, MD, M.DCorcept Therapeutics
- Intervention
- Relacorilant(drug)
- Enrollment
- 152 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2018 – 2024
Study locations (30)
- Site 21, Phoenix, Arizona, United States
- Site 36, Los Angeles, California, United States
- Site 68, Torrance, California, United States
- Site 10, Miami, Florida, United States
- Site 14, Atlanta, Georgia, United States
- Site 41, Chicago, Illinois, United States
- Site 7, Indianapolis, Indiana, United States
- Site 2, Metairie, Louisiana, United States
- Site 45, Baltimore, Maryland, United States
- Site 46, Boston, Massachusetts, United States
- Site 20, Ann Arbor, Michigan, United States
- Site 4, Jackson, Mississippi, United States
- Site 13, St Louis, Missouri, United States
- Site 53, Omaha, Nebraska, United States
- Site 72, Reno, Nevada, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03697109 on ClinicalTrials.govOther trials for Adrenal Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07168122Establishment and Clinical Application of Reference Intervals of Salivary CortisolShanghai 6th People's Hospital
- RECRUITINGNANCT06250699A Single Center Randomized Controlled Study on the Promotion of Rapid RecoveryZhe Meng
- RECRUITINGNANCT05911620Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous HypercorticismCentral Hospital, Nancy, France
- RECRUITINGNANCT05881005NAC- NAFLD and CushingUniversity Hospital, Angers
- RECRUITINGNCT06050057Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyUniversity Hospital Olomouc
- RECRUITINGNCT05521529Cushing's Syndrome Before and After Treatment (CORRECT)University of Aarhus
- ACTIVE NOT RECRUITINGNCT05446779Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden DeathHelsinki University Central Hospital
- RECRUITINGPHASE2NCT03708900Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromeRECORDATI GROUP